Eli Lilly and Company (LLY): Price and Financial Metrics
GET POWR RATINGS... FREE!
LLY POWR Grades
- Quality is the dimension where LLY ranks best; there it ranks ahead of 93.63% of US stocks.
- LLY's strongest trending metric is Quality; it's been moving down over the last 206 days.
- LLY ranks lowest in Momentum; there it ranks in the 7th percentile.
LLY Stock Summary
- LLY has a higher market value than 98.96% of US stocks; more precisely, its current market capitalization is $186,952,420,443.
- The capital turnover (annual revenue relative to shareholder's equity) for LLY is 3.69 -- better than 88.21% of US stocks.
- ELI LILLY & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.9% of US equities in our set.
- If you're looking for stocks that are quantitatively similar to ELI LILLY & Co, a group of peers worth examining would be WFC, NVO, PEP, MRK, and TMO.
- LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.
LLY Price Target
For more insight on analysts targets of LLY, see our LLY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $212.36 | Average Broker Recommendation | 1.57 (Moderate Buy) |
LLY Stock Price Chart Interactive Chart >
LLY Price/Volume Stats
| Current price | $196.21 | 52-week high | $218.00 |
| Prev. close | $194.94 | 52-week low | $129.21 |
| Day low | $194.92 | Volume | 1,823,800 |
| Day high | $197.27 | Avg. volume | 3,939,115 |
| 50-day MA | $189.35 | Dividend yield | 1.73% |
| 200-day MA | $169.62 | Market Cap | 188.17B |
Eli Lilly and Company (LLY) Company Bio
Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana.
Latest LLY News From Around the Web
Below are the latest news stories about ELI LILLY & Co that investors may wish to consider to help them evaluate LLY as an investment opportunity.
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid DrugAbCellera stock tumbled Friday, despite in-line royalties for its Lilly-partnered Covid drug. Here's why the stock toppled. |
Novo Nordisk, Eli Lilly Obesity Drugs Could Be Game ChangersMedications in a new class of drug that seem to offer substantial advantages over current treatments |
Lilly to Participate in UBS Global Healthcare Virtual ConferenceEli Lilly and Company (NYSE: LLY) will participate in the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021. Anat Ashkenazi, senior vice president and chief financial officer, will participate in a virtual fireside chat at 10:00 a.m., Eastern Time. |
New Strong Sell Stocks for May 13thPRTS, CIGI, ELMD, LLY, and TTWO have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2021 |
Eli Lilly CEO David Ricks On Alzheimer’s Disease DrugsCNBC transcript: Eli Lilly And Co (NYSE:LLY) Chairman & CEO David Ricks speaks with Meg Tirrell live during CNBC’s Healthy Returns Summit today Q1 2021 hedge fund letters, conferences and more WHEN: Today, Tuesday, May 11th WHERE: CNBC’s “Healthy Returns Summit: New Era of Innovation” CNBC’s Interview With Eli Lilly CEO David Ricks TYLER MATHISEN: […] The post Eli Lilly CEO David Ricks On Alzheimer’s Disease Drugs appeared first on ValueWalk . |
LLY Price Returns
| 1-mo | 4.14% |
| 3-mo | -4.22% |
| 6-mo | 41.19% |
| 1-year | 25.53% |
| 3-year | 154.19% |
| 5-year | 188.17% |
| YTD | 17.21% |
| 2020 | 31.04% |
| 2019 | 16.14% |
| 2018 | 40.45% |
| 2017 | 17.83% |
| 2016 | -10.37% |
LLY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching LLY
Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...